Table 2 The survival of C-BLSM and 3D-BLSM at different time intervals.
Status | Total | p value | ||||
|---|---|---|---|---|---|---|
Failure | Survived | |||||
Baseline | C-BLSM | n | 0 | 31 | 31 | – |
% | 0 | 100.0% | 100.0% | |||
3D-BLSM | n | 0 | 31 | 31 | ||
% | 0 | 100.0% | 100.0% | |||
Total | n | 0 | 62 | 62 | ||
% | 0 | 100.0% | 100.0% | |||
3 months | C-BLSM | n | 10 | 21 | 31 | 0.068 |
% | 32.3% | 67.7% | 100.0% | |||
3D-BLSM | n | 4 | 27 | 31 | ||
% | 12.9% | 87.1% | 100.0% | |||
Total | n | 14 | 48 | 62 | ||
% | 22.6% | 77.4% | 100.0% | |||
6 months | C-BLSM | n | 14 | 17 | 31 | 0.013 |
% | 45.2% | 54.8% | 100.0% | |||
3D-BLSM | n | 5 | 26 | 31 | ||
% | 16.1% | 83.9% | 100.0% | |||
Total | n | 19 | 43 | 62 | ||
% | 30.6% | 69.4% | 100.0% | |||
9 months | C-BLSM | n | 15 | 16 | 31 | 0.034* |
% | 48.4% | 51.6% | 100.0% | |||
3D-BLSM | n | 7 | 24 | 31 | ||
% | 22.6% | 77.4% | 100.0% | |||
Total | n | 22 | 40 | 62 | ||
% | 35.5% | 64.5% | 100.0% | |||
